Evidence map›Paper›PMID 30279581›Full record

ArticleProstate cancer and prostatic diseases2019

Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.

Wei Phin Tan, Dimitri Papagiannopoulos, Kalyan C Latchamsetty, Nathaniel Wilson, Nicholas O'Block, Lester Raff, Alfredo Mena Lora, Christopher L Coogan, Michael R Abern

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wei Phin TanDivision of Urology, Rush University Medical Center, Chicago, IL, USA. tanweiphin@yahoo.com.ORCID http://orcid.org/0000-0003-2651-781X
Dimitri PapagiannopoulosDivision of Urology, Rush University Medical Center, Chicago, IL, USA.
Kalyan C LatchamsettyDivision of Urology, Rush University Medical Center, Chicago, IL, USA.
Nathaniel WilsonDivision of Urology, Rush University Medical Center, Chicago, IL, USA.
Nicholas O'BlockDivision of Urology, Rush University Medical Center, Chicago, IL, USA.
Lester RaffUropartners LLC, Chicago, IL, USA.
Alfredo Mena LoraDivision of Infectious Diseases, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
Christopher L CooganDivision of Urology, Rush University Medical Center, Chicago, IL, USA.
Michael R AbernDepartment of Urology, University of Illinois Chicago, Chicago, IL, USA.
Rush University Medical Center · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceFluoroquinolone (FQ)-resistant rectal vault flora is associated with infectious complications in men undergoing transrectal ultrasound-guided prostate needle biopsy (TRUS-PNB).

objectiveTo determine the patient factors that predict FQ-resistant rectal cultures in men who are undergoing transrectal ultrasound-guided prostate needle biopsy.

methodsAn IRB approved retrospective review of 6183 consecutive men who had undergone a rectal swab culture in preparation for TRUS-PNB between January 2013 and December 2014 was performed. Multivariable logistic regression was used to determine the clinical and demographic factors associated with FQ-resistant Enterobacteriaceae in the rectal vault.

resultsOf the 6179 rectal swabs analyzed, 4842 (78%) were FQ-sensitive, and 1337 (22%) were FQ-resistant. On univariable analysis, increasing age, prior TRUS-PNB, higher number of biopsy cores obtained, diabetes mellitus, antimicrobial use within the past 6 months and non-Caucasian race were predictors of FQ-resistance (all p < 0.05). Men with FQ-resistant cultures were more likely to have benign pathology on TRUS-PNB (p = 0.004). On multivariable analysis, increasing patient age (OR = 1.01/year [1.00-1.02]), use of antimicrobials in the last 6 months (OR = 2.85[2.18-3.72]), African American (OR = 1.99 [1.66-2.37]), Asian (OR = 3.39 [2.63-4.37]), and Hispanic (OR = 2.10 [1.72-2.55]) races were independently associated with FQ-resistant rectal cultures. The overall infectious rate was 1.1% (56/5214) and the sepsis rate was 0.46% (24/5214). The infection rate in the FQ-resistant group was 3.9% (43/1107) compared to FQ-sensitive group 0.3% (13/4107), p < 0.001.

conclusionIn this cohort, increasing age, recent antimicrobial-use, and non-Caucasian race were independent predictors of FQ-resistance in the rectal vault. As FQ-resistance is associated with infectious complications from transrectal ultrasound-guided prostate needle biopsy, understanding risk factors may assist infection control efforts.

Indexed as

AgedAnti-Bacterial AgentsBacterial InfectionsBiopsyComorbidityDrug Resistance, BacterialFluoroquinolonesHumansMaleMiddle AgedNeoplasm GradingPostoperative ComplicationsProstateProstatic NeoplasmsRectumRisk FactorsAnti-Bacterial AgentsFluoroquinolones

Identifiers

PMID30279581
OpenAlexW2895630646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.